Michael Guggemos
Director/Board Member presso Regierungskommission Deutscher Corporate Governance Kodex
Profilo
Michael Guggemos is currently the Director of Regierungskommission Deutscher Corporate Governance Kodex and a Member-Supervisory Board at B.
Braun SE.
He previously worked as the Managing Director at Hans Böckler Stiftung from 2014 to 2021.
Additionally, he served as a Member-Supervisory Board at B.
Braun Melsungen AG and Aesculap AG.
Posizioni attive di Michael Guggemos
Società | Posizione | Inizio |
---|---|---|
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | Director/Board Member | 01/02/2016 |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | Director/Board Member | - |
Precedenti posizioni note di Michael Guggemos
Società | Posizione | Fine |
---|---|---|
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | Chief Executive Officer | 01/01/2021 |
Aesculap AG
Aesculap AG Medical SpecialtiesHealth Technology Aesculap AG engages in the development, manufacture, and distribution of precision, medical, as well as medical technology instruments. It also offers medical apparatus, prostheses, implants, suture materials, laboratory and hospital supplies, as well as equipment for the manufacture of medical and medical technology devices. The company was founded in 1867 and is headquartered in Tuttlingen, Germany. | Director/Board Member | - |
B. Braun Melsungen AG
B. Braun Melsungen AG Pharmaceuticals: MajorHealth Technology B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
B. Braun Melsungen AG
B. Braun Melsungen AG Pharmaceuticals: MajorHealth Technology B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany. | Health Technology |
Aesculap AG
Aesculap AG Medical SpecialtiesHealth Technology Aesculap AG engages in the development, manufacture, and distribution of precision, medical, as well as medical technology instruments. It also offers medical apparatus, prostheses, implants, suture materials, laboratory and hospital supplies, as well as equipment for the manufacture of medical and medical technology devices. The company was founded in 1867 and is headquartered in Tuttlingen, Germany. | Health Technology |
Regierungskommission Deutscher Corporate Governance Kodex
Regierungskommission Deutscher Corporate Governance Kodex General GovernmentGovernment Regierungskommission Deutscher Corporate Governance Kodex is a commission that consists of managing and supervisory board representatives of German listed companies and their stakeholders, such as institutional and retail investors, academics, auditors, and a trade union federation. It develops, reviews, and updates the code. The company was founded in September 2001 and is headquartered in Frankfurt, Germany. | Government |
Hans Böckler Stiftung (Research Firm)
Hans Böckler Stiftung (Research Firm) Investment ManagersFinance Hans Böckler Stiftung (Research Firm) (HBS-Research) is the investment research firm division of Hans Böckler Stiftung, a co-determination, research and study funding organization headquartered in Dusseldorf, Germany. Founded in 1977, HBS-Research supports third-party research projects and conducts its own research with its scientific institutes. | Finance |
B. Braun SE
B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The private company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019. | Health Technology |
- Borsa valori
- Insiders
- Michael Guggemos